home / stock / ogen / ogen news


OGEN News and Press, Oragenics Inc. From 03/10/21

Stock Information

Company Name: Oragenics Inc.
Stock Symbol: OGEN
Market: NYSE
Website: oragenics.com

Menu

OGEN OGEN Quote OGEN Short OGEN News OGEN Articles OGEN Message Board
Get OGEN Alerts

News, Short Squeeze, Breakout and More Instantly...

OGEN - Tupperware Brands, Oragenics leads the premarket losers' pack

Sundance Energy (SNDE) -42% on filing for voluntary Chapter 11 protection to strengthen balance sheet and position business for sustained future success, commences financial restructuring with lender support.INVO Bioscience (INVO) -17%.Tupperware Brands TUP -10% on Q4 earnings ...

OGEN - RIOT, SFIX, WPG and ACAD among midday movers

Gainers: Exela Technologies (XELA) +163%.Oragenics (OGEN) +47%.ReneSola (SOL) +42%.Auris Medical (EARS) +39%.The9 (NCTY) +37%.Canaan (CAN) +36%.AnPac Bio-Medical Science (ANPC) +36%.Riot Blockchain (RIOT) +35%.Washington Prime (WPG) +30%.Socket Mobile (SCKT) +23%.Losers: G...

OGEN - Oragenics inks material transfer agreement for COVID-19 vaccine adjuvants

Oragenics ([[OGEN]] +38.5%) announces that it has entered into a material transfer agreement with Biodextris for the use of three intranasal mucosal adjuvants in the company’s Terra CoV-2 vaccine against COVID-19.The initial agreement is for the three intranasal adjuvants to ...

OGEN - Best Biotech Penny Stocks To Watch Before Friday

Biotech Penny Stocks To Watch Right Now While penny stocks are well-known for volatility, so too are certain sectors. Possibly no other sector has continued its volatile trend throughout history better than biotechnology. With things like tech stocks, of course, R&D plays a role, an...

OGEN - Oragenics Enters into Material Transfer Agreement with Biodextris for Mucosal Adjuvant for Intranasal COVID-19 Vaccine

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) announced it has entered into a material transfer agreement with Biodextris Inc. for the use of three intranasal mucosal adjuvants in the Company’s Terra CoV-2 vaccine against COV...

OGEN - Oragenics to Participate in Two Investment Conferences During March

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), today announced that Alan Joslyn, Ph.D., President and Chief Executive Officer of Oragenics, will participate in two virtual investment conferences during the month of March, as follows: ...

OGEN - NVAX, GEVO, WATT and KOPN among premarket gainers

JMP Group (JMP +114% on Q4 results.Vaccinex (VCNX +88% on signing two multi-project deals.Energous Corporation (WATT +59% after report Apple working on magnetic battery pack.Taoping (TAOP +44% after entering into Consulting agreement with Great Bay Capi...

OGEN - Oragenics secures $20M capital raise

Oragenics (OGEN) announces that it has raised about $20M from the sale of its shares through an agreement with A.G.P./Alliance Global Partners for an "at-the-market" facility.The company also received about $1.9M from the exercise of common stock warrants.Oragenics has given a notice for the ...

OGEN - Oragenics Announces Recent Capital Raise and Warrant Exercises Totaling $21.9 Million and the Redemption of Its Series C Preferred Stock

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) announced it has raised approximately $20 million from the sale of common stock through a sales agreement with A.G.P./Alliance Global Partners for an “at-the-market” facili...

OGEN - KalVista Pharmaceuticals, Heat Biologics leads healthcare gainers; Aeterna Zentaris, Ekso Bionics among major losers

Gainers: KalVista Pharmaceuticals KALV +134%, Heat Biologics HTBX +70%, Iterum Therapeutics (ITRM) +48%, OrganiGram OGI +47%, Oragenics (OGEN) +24%.Losers: Aeterna Zentaris (AEZS) -27%, Ekso Bionics EKSO -23%, Ocugen OCGN -...

Previous 10 Next 10